Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

247 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Clinical Trial Highlights - Kinase Inhibitors.
Prakash N, McFarthing K, Simuni T. Prakash N, et al. Among authors: simuni t. J Parkinsons Dis. 2021;11(2):377-390. doi: 10.3233/JPD-219003. J Parkinsons Dis. 2021. PMID: 33749620 Clinical Trial. No abstract available.
Peripheral Biomarkers of Parkinson's Disease Progression and Pioglitazone Effects.
Simon DK, Simuni T, Elm J, Clark-Matott J, Graebner AK, Baker L, Dunlop SR, Emborg M, Kamp C, Morgan JC, Ross GW, Sharma S, Ravina B; NINDS NET-PD Investigators. Simon DK, et al. Among authors: simuni t. J Parkinsons Dis. 2015;5(4):731-6. doi: 10.3233/JPD-150666. J Parkinsons Dis. 2015. PMID: 26444095 Free PMC article. Clinical Trial.
Feasibility and safety of lumbar puncture in the Parkinson's disease research participants: Parkinson's Progression Marker Initiative (PPMI).
Prakash N, Caspell-Garcia C, Coffey C, Siderowf A, Tanner CM, Kieburtz K, Mollenhauer B, Galasko D, Merchant K, Foroud T, Chahine LM, Weintraub D, Casaceli C, Dorsey R, Wilson R, Herzog M, Daegele N, Arnedo V, Frasier M, Sherer T, Marek K, Frank S, Jennings D, Simuni T; Parkinson's Progression Markers InitiativeSteering Committee; Study Cores; Site Investigators; Coordinators; Industry and Scientific Advisory Board. Prakash N, et al. Among authors: simuni t. Parkinsonism Relat Disord. 2019 May;62:201-209. doi: 10.1016/j.parkreldis.2018.12.025. Epub 2019 Jan 31. Parkinsonism Relat Disord. 2019. PMID: 30738748 Free PMC article.
Clinical Trial Highlights: Targetting Alpha-Synuclein.
McFarthing K, Simuni T. McFarthing K, et al. Among authors: simuni t. J Parkinsons Dis. 2019;9(1):5-16. doi: 10.3233/JPD-189004. J Parkinsons Dis. 2019. PMID: 30741694 No abstract available.
Clinical Trial Highlights: Phase III Study in Spotlight.
McFarthing K, Simuni T. McFarthing K, et al. Among authors: simuni t. J Parkinsons Dis. 2019;9(1):3-4. doi: 10.3233/JPD-190002. J Parkinsons Dis. 2019. PMID: 30741695 No abstract available.
247 results